Tracers / [125I]NaIO3
[125I]NaIO3
- Radionuclide
- I-125 t½ 85666 min
- Modality
- Therapy
- Production route
- —
- Stage
- Reported once
- Syntheses indexed
- 1
What it is
- Compound class
- Iodate salt (oxidized radioiodine species, [125I]NaIO3)
- Target / mechanism
- —
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| Manual synthesis | — | HPLC | 62 | — | [125I]NaI Perkin Elmer, USA | 36142567 2022 Int J Mol Sci To a 600 μL solution containing 0.01 M NaIO4 in 0.1 N H2SO4 was added a 2 μL solution containing 41 kBq (1.27 μCi) of [125I]NaI. — A 62% radiochemical yield was obtained. |
Need this precursor?We can point you to suppliers for [125I]NaIO3, or handle the enquiry for you.
Get in touchNotes
Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 36142567. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.